NEW YORK (GenomeWeb) – Molecular diagnostics developer Luminex announced today that it has received clearance from the US Food and Drug Administration as well as CE-IVD marking for its in vitro diagnostic system, the Aries M1.

The M1 is a lower-throughout version of the company's Aries System, and is designed for use in smaller satellite labs. It extracts, amplifies, and detects nucleic acid targets from a variety of sample types, and can process up to six different samples and up to six PCR-based assays at a time.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.